Report Description

Forecast Period

2025-2029

Market Size (2023)

USD 7.68 Billion

Market Size (2029)

USD 12.26 Billion

CAGR (2024-2029)

8.18%

Fastest Growing Segment

Livestock

Largest Market

North America

Market Overview

Global Animal Vaccine Market has valued at USD 7.68 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.18% through 2029. Vaccines undergo a meticulous and rigorous process of testing and analysis, ensuring their safety and efficacy. This comprehensive testing includes extensive trials that span over several years, evaluating factors such as effectiveness and adoption rates of the newly developed antigen. In the post-trial stage, vaccines play a crucial role in maintaining and controlling the frequency of diseases in animals. This not only safeguards animal health but also has a significant impact on human health, considering the interdependence between humans and animals. The availability and effectiveness of animal vaccines are essential in estimating the public's reliance on animals for various purposes. Among the most commonly used animal vaccines are rabies vaccines, foot & mouth disease vaccines, and equine influenza virus vaccines. These vaccines play a pivotal role in preventing the spread of infectious agents by simulating naturally acquired immunity, thus protecting both animal and human populations from potential outbreaks and ensuring overall well-being.

Key Market Drivers

Increasing Pet Adoption Globally

Increasing pet adoption globally has brought about a surge in the demand for animal vaccines, reflecting a growing awareness of responsible pet ownership and the need to safeguard the health of our furry companions. As more people open their homes to animals in need, the risk of disease transmission among pets and from pets to humans has also risen. This necessitates comprehensive vaccination programs to ensure the well-being of these beloved family members.

One of the key drivers behind the increased demand for animal vaccines is the desire to prevent the spread of contagious diseases in crowded shelters and homes. Animal shelters, in particular, house numerous animals in close proximity, making them vulnerable to outbreaks of diseases like parvovirus and kennel cough. Vaccinations provide a vital layer of protection, not only ensuring the health of the shelter's residents but also promoting their chances of finding permanent homes.

Furthermore, as pets become more integrated into our lives, there is a growing understanding of zoonotic diseases—ailments that can be transmitted between animals and humans. This realization has led pet owners to seek vaccination for their animals to mitigate the risk of diseases such as rabies, which can be transmitted from infected pets to humans. Consequently, veterinarians are witnessing an upswing in requests for vaccines to protect both the animals and their human companions. There has been a remarkable increase in animal health awareness among the general public. People are now more informed about the importance of regular veterinary care and preventive measures to ensure the well-being of their pets. This growing awareness has led to a surge in the demand for veterinary medicines, including vaccines, driving the global expansion of the animal vaccines market. In conclusion, the rise in pet ownership, coupled with the recognition of the positive impact that companion animals have on human health, has fueled the growth of the animal vaccines market worldwide. As more families embrace their pets as valued members, the demand for effective vaccines to safeguard their health continues to grow.

Initiatives by Government Agencies, Animal Associations, and Leading Players

The demand for animal vaccines has been steadily rising due to proactive initiatives by government agencies, dedicated animal associations, and leading players in the veterinary and pharmaceutical industries. These collaborative efforts are geared towards improving animal health, mitigating disease outbreaks, and ensuring the safety of both domestic and wild animals. Government agencies play a pivotal role in driving this demand. They often implement vaccination programs to control and prevent the spread of contagious diseases in livestock and wildlife populations. These programs not only protect animal populations but also support food security and public health. For example, government-backed campaigns targeting diseases like foot-and-mouth disease and avian influenza have led to a surge in the need for vaccines in the agricultural sector.

Animal associations, including animal welfare organizations and breed-specific clubs, are also making significant contributions. They educate pet owners and breeders about the importance of vaccination in preventing common diseases among companion animals. These associations often collaborate with veterinarians to offer affordable vaccination clinics, increasing accessibility for pet owners and promoting responsible pet ownership.

Leading players in the veterinary and pharmaceutical industries are continually investing in research and development to innovate and produce more effective and efficient vaccines. Their efforts not only meet the growing demand for vaccines but also drive advancements in animal healthcare, resulting in safer and more reliable products.

Increased Prevalence of Animal Disease

Some of the most prevalent diseases among livestock and companion animals are infectious and contagious illnesses. These diseases pose a significant threat to the health and well-being of animals worldwide. For instance, highly infectious diseases such as canine distemper can easily spread through the air, putting other companion animals at risk. Similarly, conditions like foot-and-mouth disease and contagious bovine pleuropneumonia can have devastating effects on livestock, causing economic losses and impacting food production. Given the high prevalence of these diseases, there is an urgent need for effective vaccines to combat them. Vaccination not only plays a crucial role in protecting the animals but also contributes to the overall financial and physical well-being of both humans and animals. By reducing the incidence and severity of these diseases, vaccines can help ensure a healthier and more sustainable livestock and companion animal industry.

As the awareness of the importance of animal vaccines continues to grow, the demand for them is projected to rise. This increasing demand reflects the recognition of the critical role vaccines play in safeguarding animal health and welfare. By addressing the rise in disease incidence among livestock and companion animals, vaccines can contribute to a safer and more resilient animal population.


Download Free Sample Report

Key Market Challenges

Stringent Regulatory Regulations

A drug regulatory authority (DRA) plays a crucial role in ensuring the quality, safety, and efficacy of medicinal products. They oversee the entire lifecycle of these products, from manufacturing and distribution to consumer use. With a focus on maintaining product quality throughout the supply chain, DRAs diligently monitor and certify valid commercial promotions. Their responsibilities include licensing products, inspecting and licensing manufacturers and distributors, conducting post-marketing surveillance, regulating claims made for product promotion, and authorizing clinical trials. Obtaining marketing approval for new vaccines from regulatory agencies is not only a complex process but also a costly and time-consuming endeavor. The ability of companies involved in vaccine development to obtain or maintain these regulatory approvals significantly impacts their financial standing. Hence, navigating the regulatory landscape becomes a critical factor in the success of vaccine development initiatives.

High Storage Costs for Vaccines

The growth of animal vaccine demand faces a significant hindrance in the form of high storage costs. The requirement for proper storage and handling of vaccines is essential to maintain their efficacy and safety. This includes maintaining specific temperature ranges, often referred to as the cold chain, which can be both technologically and financially challenging.

The need for specialized refrigeration equipment and infrastructure increases the cost of vaccine storage. Maintaining a consistent and controlled temperature environment is vital for preserving the potency of vaccines, especially for more delicate ones. This necessity means that veterinary clinics, animal shelters, and agricultural facilities must invest in costly refrigeration systems and backup generators to prevent temperature fluctuations, particularly in areas with unreliable power supplies. The expenses associated with monitoring and quality control measures are substantial. Continuous temperature monitoring, calibration, and regular maintenance of refrigeration units are essential to ensure vaccines remain effective. These ongoing costs can strain the budgets of animal healthcare providers and organizations, discouraging them from maintaining an adequate stock of vaccines.

Key Market Trends

Increase in The Number Of R&D Activities

An increase in research and development activities aimed at designing effective, efficient, and high-quality vaccines for companion animals, such as dogs and cats, as well as farm animals, including horses, cows, and pigs, is expected to create promising opportunities for the veterinary-animal vaccines market. The launch of new products with improved efficacy and safety profiles will further contribute to the growth of this market. Moreover, significant technological advancements in the development of animal health vaccines, such as the use of novel adjuvants and delivery systems, are anticipated to drive the expansion of the veterinary-animal vaccines market during the forecast period. These advancements will enable the development of vaccines that provide superior protection against infectious diseases and promote better overall animal health.

Additionally, the increasing number of emerging markets, particularly in developing countries, presents a favorable environment for the growth of the veterinary-animal vaccines market. The rising awareness about the importance of animal health, coupled with the growing investments in veterinary infrastructure, will contribute to the increased adoption of vaccines for livestock and companion animals. Furthermore, the growing population of cattle and poultry in developing countries, along with the advancements in healthcare technology, including diagnostics and preventive care, will further accelerate the growth rate of the veterinary-animal vaccines market in the future. This is driven by the need to ensure the health and well-being of animals, which in turn has a direct impact on food security and public health. In conclusion, the veterinary-animal vaccines market is poised for significant growth due to the increasing focus on animal health, technological advancements, expanding markets, and the need for sustainable and safe food production.

Increase in Livestock Production

In livestock farming, veterinary vaccinations play a crucial role in enhancing overall productivity and ensuring the well-being of animals. Given the increasing global population, it is imperative to improve livestock production efficiency and enhance access to high-quality protein in order to meet the growing demand for food. According to the FAO High-Level Expert Forum, a projected global population of 9.1 billion people by 2050 necessitates a 70% increase in overall food production from 2005 levels. Vaccinations that safeguard animal health and bolster the supply chain are indispensable in achieving this objective. Moreover, they help reduce the reliance on antimicrobials for treating infections in both food-producing and companion animals. This is particularly important due to mounting concerns about antibiotic resistance in human and veterinary medicine, as well as the capacity of vaccinations to mitigate the proliferation of organisms that cause foodborne illnesses in humans. These factors contribute significantly to the growth potential of the market in the forecast period.

Segmental Insights

Product Insights

Based on the product, the segment of attenuated live vaccines has emerged as the dominant force in the animal vaccine market, accounting for a significant revenue share in 2023. Live attenuation stands as the oldest vaccination method employed in veterinary medicine, with ongoing trials exploring its potential for additional applications. Notably, this method is being evaluated for the development of protein subunit vaccines for swine, administered intramuscularly. These products play a pivotal role in reducing swine mortality rates and enhancing their overall lifespan amidst disease outbreaks. On the other hand, the recombinant vaccine segment exhibits remarkable growth potential throughout the forecast period. These vaccines effectively mitigate the risk of pathogenicity in animals’ post-vaccination. Moreover, recombinant vaccines possess the capability to provide immunization against multiple virus strains, as they can accommodate multiple gene inserts. This unique attribute eliminates the need for adjuvants, enhances vaccine viability, and improves overall stability. Within the realm of veterinary medicine, notable recombinant vaccines include those targeting canine distemper, pseudorabies, Newcastle disease, Lyme disease, and avian influenza.

Animal Type Insights

Based on the animal type, the livestock segment emerged as the dominant force in the market, capturing the highest revenue share. This can be attributed to several factors, including the significant increase in the livestock population, the implementation of supportive government initiatives, and the unfortunate outbreak of diseases among cattle and sheep. Looking ahead, the companion segment is poised to exhibit the fastest growth rate during the forecast period. As pet ownership continues to rise and the demand for animal companionship grows, this segment is expected to flourish, presenting lucrative opportunities for market players.


Download Free Sample Report

Regional Insights

North America, comprising the United States and Canada, is estimated to hold the largest market share in the canine disorders industry. The increasing incidence of canine disorders, including but not limited to allergies, respiratory issues, and gastrointestinal problems, has led to a higher adoption of vaccination and preventive measures in the region. This, coupled with the rising pet population and the presence of ongoing research projects and initiatives, is expected to further boost the market in North America. The region's commitment to pet healthcare and continuous advancements in research and development contribute to its dominant position in the market. Efforts are being made to understand the root causes of various canine disorders and develop innovative treatments and therapies to improve the overall well-being of our beloved furry companions. The collaborative efforts of veterinarians, scientists, and pet owners in North America pave the way for advancements in the field of veterinary medicine, ensuring the best possible care for our four-legged friends.

Recent Developments

  • In July 2023, the College of Veterinary Medicine at Kansas State University, United States launched the establishment of the Center on Vaccine Evaluation and Alternatives for Antimicrobials (CVEAA) aimed at bolstering the development and utilization of animal vaccines. The centre is dedicated to research and service and is specifically tailored to address various unmet requirements within the global landscape of animal vaccine development and deployment.
  • In June 2023, Boehringer Ingelheim Animal Health Canada Inc. introduced a vaccine combination designed to provide protection against two of the most destructive and economically impactful swine diseases in a single dose. Utilizing a proprietary purification technique, Boehringer Ingelheim's Ingelvac CircoFLEX can now be combined with the market leading Ingelvac porcine reproductive and respiratory syndrome (PRRSv) MLV without compromising protection against PRRS.

Key Market Players

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Biogenesis Bago SA
  • Indian Immunologicals Ltd.
  • Elanco Animal Health Incorporated
  • Phibro Animal Health Corporation
  • Neogen Corporation
  • Intas Pharmaceuticals Ltd.
  • Ouro Fino Saude Animal

 By Product

By Animal Type

By Route Of Administration

By Distribution Channel

By Region

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Livestock
  • Companion
  • Others
  • Subcutaneous
  • Intramuscular
  • Intranasal
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global Animal Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Animal Vaccine Market, By Product:

o   Attenuated Live Vaccines

o   Inactivated Vaccines

o   Subunit Vaccines

o   DNA Vaccines

o   Recombinant Vaccines

  • Animal Vaccine Market, By Animal Type:

o   Livestock

o   Companion

o   Others  

  • Animal Vaccine Market, By Route of Administration:

o   Subcutaneous

o   Intramuscular

o   Intranasal

  • Animal Vaccine Market, By Distribution Channel:

o   Veterinary Hospitals

o   Veterinary Clinics

o   Pharmacies & Drug Stores

o   Others

  • Animal Vaccine Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Vaccine Market.

Available Customizations:

Global Animal Vaccine market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Animal Vaccine Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.           Markets Covered

1.2.2.           Years Considered for Study

1.2.3.           Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validations

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Animal Vaccine Market Outlook

5.1.  Market Size & Forecast

5.1.1.           By Value

5.2.  Market Share & Forecast

5.2.1.           By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)

5.2.2.           By Animal Type (Livestock, Companion, Others)

5.2.3.           By Route Of Administration (Subcutaneous, Intramuscular, Intranasal)

5.2.4.           By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others)

5.2.5.           By Region

5.2.6.           By Company (2023)

5.3.  Market Map

6.    North America Animal Vaccine Market Outlook

6.1.  Market Size & Forecast       

6.1.1.           By Value

6.2.  Market Share & Forecast

6.2.1.           By Product

6.2.2.           By Animal Type

6.2.3.           By Route Of Administration

6.2.4.           By Distribution Channel

6.2.5.           By Country

6.3.  North America: Country Analysis

6.3.1.           United States Animal Vaccine Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.            By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.            By Product

6.3.1.2.2.            By Animal Type

6.3.1.2.3.            By Route Of Administration

6.3.1.2.4.            By Distribution Channel

6.3.2.           Canada Animal Vaccine Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.            By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.            By Product

6.3.2.2.2.            By Animal Type

6.3.2.2.3.            By Route Of Administration

6.3.2.2.4.            By Distribution Channel

6.3.3.           Mexico Animal Vaccine Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.            By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.            By Product

6.3.3.2.2.            By Animal Type

6.3.3.2.3.            By Route Of Administration

6.3.3.2.4.            By Distribution Channel

7.    Europe Animal Vaccine Market Outlook

7.1.  Market Size & Forecast       

7.1.1.           By Value

7.2.  Market Share & Forecast

7.2.1.           By Product

7.2.2.           By Animal Type

7.2.3.           By Route Of Administration

7.2.4.           By Distribution Channel

7.2.5.           By Country

7.3.  Europe: Country Analysis

7.3.1.           Germany Animal Vaccine Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.            By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.            By Product

7.3.1.2.2.            By Animal Type

7.3.1.2.3.            By Route Of Administration

7.3.1.2.4.            By Distribution Channel

7.3.2.           United Kingdom Animal Vaccine Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.            By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.            By Product

7.3.2.2.2.            By Animal Type

7.3.2.2.3.            By Route Of Administration

7.3.2.2.4.            By Distribution Channel

7.3.3.           Italy Animal Vaccine Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.            By Value

7.3.3.2.        Market Share & Forecasty

7.3.3.2.1.            By Product

7.3.3.2.2.            By Animal Type

7.3.3.2.3.            By Route Of Administration

7.3.3.2.4.            By Distribution Channel

7.3.4.           France Animal Vaccine Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.            By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.            By Product

7.3.4.2.2.            By Animal Type

7.3.4.2.3.            By Route Of Administration

7.3.4.2.4.            By Distribution Channel

7.3.5.           Spain Animal Vaccine Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.            By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.            By Product

7.3.5.2.2.            By Animal Type

7.3.5.2.3.            By Route Of Administration

7.3.5.2.4.            By Distribution Channel

8.    Asia-Pacific Animal Vaccine Market Outlook

8.1.  Market Size & Forecast       

8.1.1.           By Value

8.2.  Market Share & Forecast

8.2.1.           By Product

8.2.2.           By Animal Type

8.2.3.           By Route Of Administration

8.2.4.           By Distribution Channel

8.2.5.           By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.           China Animal Vaccine Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.            By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.            By Product

8.3.1.2.2.            By Animal Type

8.3.1.2.3.            By Route Of Administration

8.3.1.2.4.            By Distribution Channel

8.3.2.           India Animal Vaccine Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.            By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.            By Product

8.3.2.2.2.            By Animal Type

8.3.2.2.3.            By Route Of Administration

8.3.2.2.4.            By Distribution Channel

8.3.3.           Japan Animal Vaccine Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.            By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.            By Product

8.3.3.2.2.            By Animal Type

8.3.3.2.3.            By Route Of Administration

8.3.3.2.4.            By Distribution Channel

8.3.4.           South Korea Animal Vaccine Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.            By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.            By Product

8.3.4.2.2.            By Animal Type

8.3.4.2.3.            By Route Of Administration

8.3.4.2.4.            By Distribution Channel

8.3.5.           Australia Animal Vaccine Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.            By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.            By Product

8.3.5.2.2.            By Animal Type

8.3.5.2.3.            By Route Of Administration

8.3.5.2.4.            By Distribution Channel

9.    South America Animal Vaccine Market Outlook

9.1.  Market Size & Forecast       

9.1.1.           By Value

9.2.  Market Share & Forecast

9.2.1.           By Product

9.2.2.           By Animal Type

9.2.3.           By Route Of Administration

9.2.4.           By Distribution Channel

9.2.5.           By Country

9.3.  South America: Country Analysis

9.3.1.           Brazil Animal Vaccine Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.            By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.            By Product

9.3.1.2.2.            By Animal Type

9.3.1.2.3.            By Route Of Administration

9.3.1.2.4.            By Distribution Channel

9.3.2.           Argentina Animal Vaccine Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.            By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.            By Product

9.3.2.2.2.            By Animal Type

9.3.2.2.3.            By Route Of Administration

9.3.2.2.4.            By Distribution Channel

9.3.3.           Colombia Animal Vaccine Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.            By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.            By Product

9.3.3.2.2.            By Animal Type

9.3.3.2.3.            By Route Of Administration

9.3.3.2.4.            By Distribution Channel

10.  Middle East and Africa Animal Vaccine Market Outlook

10.1.            Market Size & Forecast         

10.1.1.        By Value

10.2.            Market Share & Forecast

10.2.1.        By Product

10.2.2.        By Animal Type

10.2.3.        By Route Of Administration

10.2.4.        By Distribution Channel

10.2.5.        By Country

10.3.            MEA: Country Analysis

10.3.1.        South Africa Animal Vaccine Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Product

10.3.1.2.2.         By Animal Type

10.3.1.2.3.         By Route Of Administration

10.3.1.2.4.         By Distribution Channel

10.3.2.        Saudi Arabia Animal Vaccine Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Product

10.3.2.2.2.         By Animal Type

10.3.2.2.3.         By Route Of Administration

10.3.2.2.4.         By Distribution Channel

10.3.3.        UAE Animal Vaccine Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Product

10.3.3.2.2.         By Animal Type

10.3.3.2.3.         By Route Of Administration

10.3.3.2.4.         By Distribution Channel

11.  Market Dynamics

11.1.            Drivers

11.2.            Challenges

12.  Market Trends & Developments

12.1.            Merger & Acquisition (If Any)

12.2.            Product Launches (If Any)

12.3.            Recent Developments

13.  Porters Five Forces Analysis

13.1.            Competition in the Industry

13.2.            Potential of New Entrants

13.3.            Power of Suppliers

13.4.            Power of Customers

13.5.            Threat of Substitute Products

14.  Competitive Landscape

14.1.            Zoetis Inc.

14.1.1.        Business Overview

14.1.2.        Company Snapshot

14.1.3.        Products & Services

14.1.4.        Financials (As Reported)

14.1.5.        Recent Developments

14.1.6.        Key Personnel Details

14.1.7.        SWOT Analysis

14.2.            Merck & Co., Inc.

14.3.            Boehringer Ingelheim International GmbH

14.4.            Biogenesis Bago SA

14.5.            Indian Immunologicals Ltd.

14.6.            Elanco Animal Health Incorporated

14.7.            Phibro Animal Health Corporation

14.8.            Neogen Corporation

14.9.            Intas Pharmaceuticals Ltd.

14.10.         Ouro Fino Saude Animal

15.  Strategic Recommendations

16.  About Us & Disclaimer

Figures and Tables


Frequently asked questions

down-arrow

The market size of the global animal vaccine market was estimated to be USD 7.68 Billion in 2023.

down-arrow

Based on product, the attenuated live vaccines segment holds the largest market share during the forecast period. Live attenuation, a well-established and time-tested vaccination technique, has been widely utilized in the veterinary field for years. The continuous exploration and refinement of this technique demonstrate its enduring significance and potential for advancements in veterinary medicine.

down-arrow

North America is projected to experience growth in the veterinary-animal vaccines market during the forecast period. This is attributed to the increasing incidence of livestock and zoonotic diseases, leading to significant animal mortality in the region.

down-arrow

Increase in pet ownership in developed countries and rise in number of cattle & poultry are the major drivers for the Global Animal Vaccine Market.

profile

Sakshi Bajaal

Business Consultant
Press Release

Bulk Metallic Glass Market to Grow with a CAGR of 3.56% Globally through 2029

Feb, 2024

Surge in research and development activities is expected to drive the Global Bulk Metallic Glass Market growth in the forecast period, 2025-2029.